Publications by authors named "Seval Ay"

Claim this Profile
T
Treatment outcomes of sunitinib and/or pazopanib in advanced alveolar soft part sarcoma: A Turkish Oncology Group (TOG) study.
Zehra Sucuoğlu İşleyen, Seval Ay, Ertuğrul Bayram, Şaban Seçmeler, Oğuzhan Selvi, Sabin Göktaş Aydın, Özlem Aydın İsak, Murat Ayhan, Kayhan Ertürk

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study.
Özgecan Dülgar, Sema Türker, Gül Başaran, Murat Araz, Ahmet Taner Sümbül, Dilek Çağlayan, Özge Gümüşay, Ayşe İrem Yasin, Erkan Kayıkçıoğlu, Seval Ay

J Chemother· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of HER2 Status Assessed by Immunohistochemistry on Treatment Response in Patients with Metastatic Breast Cancer Receiving Trastuzumab Emtansine.
Sila Oksuz, Oguzcan Kinikoglu, Ugur Ozkerim, Yunus Emre Altintas, Deniz Isik, Seval Ay

Medicina (Kaunas)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of mucinous histology in left‑sided metastatic colorectal cancers with wild‑type RAS and evaluation of backbone chemotherapy regimens.
Rukiye Arikan, Muhammed Mustafa Atci, Seval Ay, Murat Ayhan, Nazim Can Demircan, Ibrahim Vedat Bayoglu, Faysal Dane

Oncol Lett· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study.
Muhammed Mustafa Atci, Baran Akagunduz, Metin Demir, Rukiye Arikan, Seval Ay, Murat Ayhan, Gökhan Karakaya

J Chemother· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Predictive Importance of Body Mass Index on Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer.
Levent Emirzeoglu, Serdar Arici, Ahmet Bilgehan Sahin, Birol Ocak, Naziye Ak, Seval Ay

Breast Care (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is adipose tissue metabolic activity a predictor of pathological responses to neoadjuvant treatment in breast cancer.
Ozgecan Dulgar, Ebru Orsal Ibisoglu, Seval Ay, Hatice Uslu, Mahmut Gümüş

Rev Esp Med Nucl Imagen Mol (Engl Ed)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer.
Seval Ay, Muhammed Mustafa Atcı, Rukiye Arıkan, Özgecan Dülgar, Deniz Tataroğlu Özyükseler

J Chemother· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?
Özgecan Dülgar, Başak Bala Öven, Muhammed Mustafa Atcı, Rukiye Arıkan, Seval Ay, Murat Ayhan, Ertuğrul Bayram, Ayşe İrem Yasin

Expert Rev Anticancer Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer.
Atakan Topcu, Muhammed Mustafa Atci, Saban Secmeler, Mehmet Besiroglu, Murat Ayhan, Oktay Bozkurt, Seval Ay, Caglayan Geredeli, Ayse Irem Yasin

Future Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the duration of castration resistance predictive for sequential treatment responses in the metastatic castration-resistant prostate cancer setting?
Özgecan Dülgar, Deniz Tataroğlu Özyükseler, Mustafa Başak, Seval Ay, Deniz Tural

J Oncol Pharm Pract· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of mean platelet volume in nonalcoholic fatty liver disease without cardiovascular comorbidities, obesity and diabetes mellitus.
Can Tuzer, Yasar Sertbas, Emrah Duman, Sabiha Komoglu, Omer Kan, Seval Ay, Aysegul Dalbeler

Eur J Gastroenterol Hepatol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial Ca 125 Value as a Predictive Marker for High-grade Serous Ovarian Cancer.
Seval Ay, Deniz Tataroglu Ozyukseler, Ozgecan Dulgar, Mustafa Basak, Mahmut Emre Yildirim

J Coll Physicians Surg Pak· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of tumor location on high-grade serous ovarian cancer prognosis.
Seval Ay, Deniz Tataroğlu Özyükseler, Mustafa Başak, Özgecan Dülgar, Serdar Arıcı

Ginekol Pol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors of ado-trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer.
Deniz Tataroglu Ozyukseler, Mustafa Basak, Seval Ay, Aygül Koseoglu, Serdar Arıcı

J Oncol Pharm Pract· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study.
Muhammed Mustafa Atcı, Çağlayan Geredeli, Seval Ay, Abdullah Sakin, Biray Ertürk

Eur J Breast Health· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of pharmacist interventions and commonly used medications in the geriatric ward of a teaching hospital in Turkey: a retrospective study.
Elif Ertuna, Mehmet Zuhuri Arun, Seval Ay, Fatma Özge Kayhan Koçak, Bahattin Gökdemir

Clin Interv Aging· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis